New Zealand markets closed

NRx Pharmaceuticals, Inc. (NRXP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.7402+0.0150 (+2.07%)
As of 12:05PM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
Total revenue
0
0
0
Operating expenses
Research development
21,130
20,257
10,625
Selling general and administrative
77,250
74,944
11,436
Total operating expenses
98,380
94,430
11,901
Operating income or loss
-98,380
-94,430
-11,901
Interest expense
11
18
56
Total other income/expenses net
10,481
1,385
-39,820
Income before tax
-87,887
-93,063
-51,777
Income tax expense
-
0
0
Income from continuing operations
-87,887
-93,063
-51,777
Net income
-87,887
-93,063
-51,777
Net income available to common shareholders
-87,887
-348,885
-51,777
Basic EPS
-
-7.44
-1.51
Diluted EPS
-
-7.44
-1.51
Basic average shares
-
46,918
34,271
Diluted average shares
-
46,918
34,271
EBITDA
-
-93,043
-51,719